Literature DB >> 17934809

Comparative studies on expression of alpha-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C.

Chia-Ming Chu1, Wei-Chue Shyu, Yun-Fan Liaw.   

Abstract

BACKGROUND/AIMS: Chronic hepatitis B and hepatitis C are common causes of liver fibrosis and cirrhosis. We performed a comparative study on the expression of alpha-smooth muscle actin (alpha-SMA) in hepatic stellate cells (HSCs), a marker of HSC activation, in patients with chronic hepatitis B and hepatitis C. PATIENTS AND METHODS: Using immunohistochemistry and a semi-quantitative scoring method, the expression of alpha-SMA in HSCs was studied in patients with chronic hepatitis B (n = 50) and hepatitis C (n = 50). The HSC activation index was correlated with age, sex, AST, ALT, viral genotype, viral titers, degrees of hepatic steatosis, necroinflammatory grades and fibrotic stages.
RESULTS: The HSC activation index correlated significantly (P < 0.05) with necroinflmmatory grades and fibrotic stages in chronic hepatitis B or hepatitis C. Besides, the HSC activation index also correlated significantly (P < 0.05) with hepatic steatosis and marginally significantly (P = 0.08) with serum viral titers in chronic hepatitis C. There was no significant difference in biochemical and histological activities between patients with hepatitis B and hepatitis C, but the latter had a significantly higher HSC activation index than the former. Multiple regression analysis in all 100 patients showed that the HSC activation index correlated significantly (P < 0.05) with necroinflammatory grades, fibrotic stages and hepatitis C (versus hepatitis B).
CONCLUSION: In chronic viral hepatitis, the HSC activation index correlated significantly and independently with necroinflammation and fibrosis. Additionally, the HSC activation index was significantly higher in patients with chronic hepatitis C. These data may be compatible with the postulation that hepatitis C virus can directly activate HSCs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934809     DOI: 10.1007/s10620-007-9997-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts.

Authors:  M Guido; M Rugge; G Leandro; I M Fiel; S N Thung
Journal:  Hepatology       Date:  1997-08       Impact factor: 17.425

Review 2.  Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease.

Authors:  R P Perrillo
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

3.  Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy.

Authors:  M Guido; M Rugge; L Chemello; G Leandro; G Fattovich; G Giustina; M Cassaro; A Alberti
Journal:  J Hepatol       Date:  1996-03       Impact factor: 25.083

Review 4.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

5.  Relationship of aminotransferases to liver histological status in chronic hepatitis C.

Authors:  M M Haber; A B West; A D Haber; A Reuben
Journal:  Am J Gastroenterol       Date:  1995-08       Impact factor: 10.864

6.  HCV core protein localizes in the nuclei of nonparenchymal liver cells from chronically HCV-infected patients.

Authors:  Viviana Falcón; Nelson Acosta-Rivero; Mineko Shibayama; Glay Chinea; Jorge V Gavilondo; María C de la Rosa; Ivón Menéndez; Bienvenido Gra; Santiago Dueñas-Carrera; Ariel Viña; Waldo García; Maritza González-Bravo; Jose Luna-Munoz; Magdalena Miranda-Sanchez; Juan Morales-Grillo; Juan Kouri; Victor Tsutsumi
Journal:  Biochem Biophys Res Commun       Date:  2005-04-22       Impact factor: 3.575

7.  Pilot study of interferon-alpha and ribavirin treatment in patients with chronic hepatitis C and normal transaminase values.

Authors:  S S Lee; M Sherman
Journal:  J Viral Hepat       Date:  2001-05       Impact factor: 3.728

8.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 9.  Liver fibrosis: from the bench to clinical targets.

Authors:  M Pinzani; K Rombouts
Journal:  Dig Liver Dis       Date:  2004-04       Impact factor: 4.088

10.  Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells.

Authors:  Ramó Bataller; Yong-Han Paik; Jeffrey N Lindquist; John J Lemasters; David A Brenner
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

View more
  7 in total

1.  Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice.

Authors:  Wen-Ling Kuo; Ming-Chin Yu; Ju-Fang Lee; Chi-Neu Tsai; Tse-Ching Chen; Miin-Fu Chen
Journal:  J Gastrointest Surg       Date:  2011-11-09       Impact factor: 3.452

Review 2.  Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants.

Authors:  Eu Jin Lim; Ruth Chin; Peter W Angus; Joseph Torresi
Journal:  World J Gastroenterol       Date:  2012-05-14       Impact factor: 5.742

3.  Hepatocellular autophagy modulates the unfolded protein response and fasting-induced steatosis in mice.

Authors:  Wilhelmus J Kwanten; Yves-Paul Vandewynckel; Wim Martinet; Benedicte Y De Winter; Peter P Michielsen; Viviane O Van Hoof; Ann Driessen; Jean-Pierre Timmermans; Pierre Bedossa; Hans Van Vlierberghe; Sven M Francque
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.052

4.  Diethylcarbamazine reduces chronic inflammation and fibrosis in carbon tetrachloride- (CCl₄-) induced liver injury in mice.

Authors:  Sura Wanessa Santos Rocha; Maria Eduarda Rocha de França; Gabriel Barros Rodrigues; Karla Patrícia Sousa Barbosa; Ana Karolina Santana Nunes; André Filipe Pastor; Anne Gabrielle Vasconcelos Oliveira; Wilma Helena Oliveira; Rayana Leal Almeida Luna; Christina Alves Peixoto
Journal:  Mediators Inflamm       Date:  2014-10-13       Impact factor: 4.711

5.  iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine.

Authors:  Jiankun Yang; Lichao Yang; Baixue Li; Weilong Zhou; Sen Zhong; Zhenhua Zhuang; Bin Yang; Maoshan Chen; Quansheng Feng
Journal:  Biomed Res Int       Date:  2016-11-29       Impact factor: 3.411

6.  Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease.

Authors:  Ahmed M Gharib; Ma Ai Thanda Han; Eric G Meissner; David E Kleiner; Xiongce Zhao; Mary McLaughlin; Lindsay Matthews; Bisharah Rizvi; Khaled Z Abd-Elmoniem; Ralph Sinkus; Elliot Levy; Christopher Koh; Robert P Myers; G Mani Subramanian; Shyam Kottilil; Theo Heller; Joseph A Kovacs; Caryn G Morse
Journal:  Biomed Res Int       Date:  2017-04-05       Impact factor: 3.411

7.  Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology.

Authors:  Rada Teodora Sufleţel; Carmen Stanca Melincovici; Bogdan Alexandru Gheban; Zaharie Toader; Carmen Mihaela Mihu
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.